Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
4JUL

18 scientists move west to UK labs

2 min read
11:24UTC

DSIT reported on 5 June that 18 researchers had joined UK institutions via the £54m UKRI Global Talent Fund, recruited from Stanford, Yale, Columbia and elsewhere as American federal science budgets contract.

TechnologyDeveloping
Key takeaway

British labs are pulling senior US-based scientists west as American federal science funding contracts.

DSIT reported on Friday 5 June that ten more researchers had joined UK institutions through the UKRI Global Talent Fund, a £54m pot administered by UK Research and Innovation (UKRI), taking the running total to 18. The named recruits left posts at Oregon State, Stanford, Columbia, UC San Diego, Yale and Tel Aviv. Professor Bryony DuPont moved from Oregon State to Strathclyde for AI in energy systems; Professor Laura Huckins left Yale for Bath to work on psychiatric genetics. 1

The timing tracks cuts to United States federal science budgets under the current administration, which have left researchers looking for stable funding abroad. These are placements, not promises: named people in named labs, expected to seed spinout activity over the coming years. Not every recruit founds a company, and the fund buys research capacity rather than guaranteed ventures.

The Advanced Research and Invention Agency (ARIA), the UK's high-risk research funder modelled on DARPA, reported a sharper conversion from its Encode fellowship, which pays researchers to spin out companies. Two proto-companies emerged from 18 fellows in four months, after which the government added £5m to double the cohort.

Britain signed a researcher-mobility deal with France in May, committing annual funding to early-career exchange . The Global Talent Fund and ARIA are the domestic side of the same effort, moving people as well as money into UK science.

Deep Analysis

In plain English

American universities and research labs have been cutting positions as the US federal science budget shrinks under the current administration. Some of those researchers are choosing to move abroad. The UK government set up a £54m fund specifically to recruit senior scientists from overseas. In the first wave, 18 researchers moved from Stanford, Columbia, Yale, and other American and Israeli institutions into UK university labs. Separately, ARIA, a UK agency modelled on the American DARPA programme, ran a four-month fellowship that explicitly allowed researchers to spend time founding companies. Two of the 18 fellows who went through the programme started proto-companies, which is an unusually high rate.

Deep Analysis
Root Causes

The US National Institutes of Health lost approximately $2bn in funding commitments in the first quarter of 2025 following Congressional budget reconciliation. The National Science Foundation faced a further 10% proposed cut in the 2026 federal budget request. These cuts affect postdoctoral and early-career researchers most severely, because their positions depend on grant renewal rather than tenure.

UK salary competitiveness has also improved relative to the US for mid-career researchers. The weak dollar (USD/GBP at 0.79 in May 2026) means a UK salary in sterling buys more in US-dollar terms than at any point since 2014, reducing the financial penalty of moving west.

ARIA's Encode fellowship operates differently from UKRI grant mechanisms: fellows receive a fixed-term stipend with explicit permission to spend time on company formation, removing the conflict-of-interest constraint that blocks most UK university researchers from serious commercialisation activity during their grant periods.

What could happen next?
  • Opportunity

    UK deep-tech companies now have a pool of recently-arrived senior US-trained scientists at UK institutions who are institutionally primed for commercial collaboration.

    Short term · Assessed
  • Risk

    If US federal science funding stabilises or recovers, the talent flow reverses: researchers recruited under time-limited packages may return to American institutions when their UK terms end.

    Medium term · Assessed
  • Consequence

    ARIA's 11% company-formation rate from the Encode cohort gives the agency a stronger case than any UK university technology transfer office for running the next wave of commercialisation funding.

    Short term · Assessed
First Reported In

Update #7 · OQC's £260m sets European quantum record

UK Tech News· 7 Jun 2026
Read original
Different Perspectives
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
The three US growth-capital firms backed Helsing's $1.8bn round at an $18bn valuation, more than doubling the mark set only a year earlier, with demand reportedly exceeding the capital on offer. Their money, not a UK sovereign vehicle, is what funds the Plymouth plant, extending a pattern of foreign capital underwriting British defence-hardware manufacturing this cycle.
British Business Bank
British Business Bank
The Bank wrote its largest-ever direct life-sciences cheque into Alchemab and added a £6.5bn SME lending guarantee the same week UKRI confirmed the STFC cuts. It is deploying an April mandate change letting it lead venture rounds and invest directly up to £60m per company, treating equity extension rounds and small-business debt as newly within its risk appetite.
Daphni
Daphni
The Paris seed fund joined Speedinvest and three UK backers in Astral Systems' GBP23m Series A for modular fusion reactors, one of the round's five European co-investors betting on lab-to-market fusion ahead of any working commercial reactor. Unlike CuspAI's all-foreign cap table, this round kept a UK lead investor in Mercia Ventures.
EQT
EQT
EQT, appointed by the European Innovation Council to run the EUR5bn Scaleup Europe Fund, entered advanced talks for a further CuspAI stake reported on 3 July, the fund's first pursuit of a UK-founded winner. A closed deal would put EU sovereign capital, not a UK vehicle, on the cap table of a company Britain's own funds passed over.